BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  NeurogesX, Inc. Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

  July 24, 2009

   · 

  1 min read
• Business

  Targeted Genetics Corporation Amends Seattle Headquarters Facility Lease; Company Continues to Scale Down; Employees Reduced To Approximately 15 at August 1, 2009

  July 24, 2009

   · 

  6 min read
• Business

  Calypso Medical Technologies and Varian Medical Systems Enter into Master Development Agreement for Radiation Therapy Cancer Treatment

  July 24, 2009

   · 

  1 min read
• Pharm Country

  Company Profile for NPS Pharmaceuticals, Inc.

  July 24, 2009

   · 

  1 min read
• Biotech Beach

  Cytori Therapeutics, Inc. Comments on Patent Appeal

  July 24, 2009

   · 

  1 min read
• Drug Development

  Ambrilia Biopharma Inc.: Termination of Study 303 and Update On C2L Development

  July 24, 2009

   · 

  3 min read
• Drug Development

  Seattle Genetics, Inc. Initiates Brentuximab Vedotin (SGN-35) Retreatment Clinical Trial

  July 24, 2009

   · 

  1 min read
• PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

  July 24, 2009

   · 

  1 min read
• Business

  United Therapeutics Corporation to Announce Second Quarter 2009 Financial Results Before Market Open on Friday, July 31, 2009

  July 24, 2009

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited and Ortho-McNeil-Janssen Pharmaceuticals, Inc. Settle Ortho Tri-Cyclen(R) Lo Litigation

  July 24, 2009

   · 

  1 min read